Form D · Biotechnology

HCW Biologics Inc.

Miramar, FL · CIK 0001828673

Offering snapshot reported Oct 8, 2026 · SEC filing

Reported sold
$1.5M
Offering amount: $1.5M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 24, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 8, 2026Initial$1,500,000No comparison1SEC filing
Aug 6, 2026Initial$1,600,000No comparison4SEC filing
Jun 8, 2026Initial$4,000,000No comparison7SEC filing
Dec 5, 2024Initial$6,918,254No comparison1SEC filing
Feb 27, 2024Initial$2,500,005No comparison6SEC filing
Oct 19, 2020Initial$6,168,320No comparison9SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-600457

Source: Form D, filed Oct 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Rebecca Byam Executive
Lee Flower Executive
Lee Flowers Executive
Scott Garrett Director
Lisa Giles Director
Rick Greene Director
Fred M. Middleton Director
Peter Rhode Executive
Peter Sun Director
Nicole Valdivieso Executive
Gary M. Winer Director
Hing Wong Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2929 N. Commerce Parkway
Miramar, FL, 33025
Phone: 954-842-2024